Abstract:Background A retrospective utilization study was performed to evaluate utilization patterns for enteral nutrition in a university teaching hospital. Methods Enteral nutrition was divided into three types according to the nitrogen source, ie, total protein type [Nutrison Fibre®, Fresubin Energy Fibre®, Fresubin®, Supportan® (a special immunonutrition for cancer patients or patients with increased demands for omega-3 fatty acids), Fresubin Diabetes® (a diabetes-specific formula), Ensure®]; short peptide type (Peptison®); and amino acid type (Vivonex®). A pharmacoeconomic analysis was done based on defined daily dose methodology. Results Among hospitalized patients taking enteral nutrition, 34.8% received enteral nutrition alone, 30% concomitantly received parenteral nutrition, and 35.2% received enteral nutrition after parenteral nutrition. Combined use of the different formulas was observed in almost all hospitalized patients receiving enteral nutrition. In total, 61.5% of patients received triple therapy with Nutrison Fibre, Fresubin Diabetes, and Supportan. Number of defined daily doses (total dose consumed/defined daily dose, also called DDDs) of formulas in descending order were as follows: Nutrison Fibre, Fresubin Energy Fibre, Fresubin Diabetes > Supportan > Peptison, Ensure > Vivonex, Fresubin. The ratio of the cumulative DDDs for the three types of enteral nutrition was 35:2.8:1 (total protein type to short peptide type to amino acid type). Off-label use of Fresubin Diabetes was also observed, with most of this formula being prescribed for patients with stress hyperglycemia. Only 2.1% of cancer patients received Supportan. There were 35 cases of near misses in dispensing look-alike or sound-alike enteral nutrition formulas, and one adverse drug reaction in an elderly malnourished patient who did not receive vitamin K1-enriched enteral nutrition during treatment with cefoperazone. After 4 months of the trial intervention, off-label use of Fresubin Diabetes was no longer endorsed by the Drug and Therapeutics Committee for nondiabetic patients, and the proportion of this formula prescribed for patients with stress hyperglycemia decreased by 20%, with a 10-fold increase in the amount of Supportan prescribed for cancer patients. Near misses in dispensing look-alike or sound-alike enteral nutrition were successfully abolished, and no severe coagulation disorders occurred after prophylactic administration of vitamin K1-enriched enteral nutrition in elderly malnourished patients receiving cefoperazone. Conclusion This utilization study indicates that continuous quality improvement is necessary and that a Drug and Therapeutics Committee can play an important role in promoting rational and safe use of enteral nutrition. Appropriateness of this therapy still needs to be improved, especially in addressing the issues of non-evidence-based combined use of multiple enteral nutrition formulas, the relatively high rate of concomitant use of enteral and parenteral nutrition, off-label use of diabetes-specific Fresubin Diabetes, insufficient use of Supportan in cancer patients, and unnecessary use of Supportan in intensive care patients not suffering from cancer.

Muti-center clinical researches of new oral enteral nutrition in patients

Prescribing Practice and Evaluation of Appropriateness of Enteral Nutrition in a University Teaching Hospital

Early Enteral Nutrition Support Dose Selection in Critically Ill Patients: a Meta Analysis

Effects of different postoperative nutritional support on oxidative stress and clinical outcomes for patients after gastrointestinal surgery

A more physiological feeding process in ICU: Intermittent infusion with semi-solid nutrients (CONSORT-compliant).

[Retrospective Survey of Nutritional Support Therapy in Adult Patients after Severe Burn].

A cross-sectional study on nutritional status of ICU patients in the mainland China

Clinical study about nutritional risk screening and early postoperative enteral nutrition support in elderly pa-tients with colorectal cancer

Parenteral and enteral nutrition and translational medicine T3: discussion on clinical study design for standardized application and patient benefit

Clinical experience of patients with home enteral nutrition in a single center of China

Clinical analysis of enteral nutrition in 47 children

Clinical Application of Enteral Nutrition Combined with Microbial Preparation for Intestinal Preparation in Elderly Patients with Colorectal Cancer

Supplementation through percutaneous endoscopic gastrostomy improves nutritional status in oral and maxillofacial malignant tumor patients undergoing comprehensive management

Clinical study of different nutrition support for patients with perioperative esophageal cancer

Clinical study on early enteral nutrition in postoperative patients with gastric cancer

Influence of different enteral nutritional support regimens on the nutritional status of post-operative patients with gastric cancer

Efficacy and Safety of Pectin-Supplemented Enteral Nutrition in Intensive Care: A Randomized Controlled Trial

Nutrition delivery during hospitalisation after critical illness in Australia and New Zealand: a multicentre, prospective observational study

Construction of a three-level enteral nutrition nursing system under the “Internet + medical” mode and an evaluation of its effect in clinical application

Study for early postoperative enteral nutrition via nasointestinal tube for patients with oral cancer

Effects of different nutritional intervention for nutrition status of inpatients in coma